198 related articles for article (PubMed ID: 17910029)
61. Toll-like receptors-related genes in kidney transplant patients with chronic allograft nephropathy and acute rejection.
Nogueira E; Ponciano VC; Naka EL; Marques GD; Cenedeze MA; Câmara NO; Pacheco-Silva A
Int Immunopharmacol; 2009 Jun; 9(6):673-6. PubMed ID: 19105982
[TBL] [Abstract][Full Text] [Related]
62. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
[TBL] [Abstract][Full Text] [Related]
63. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome.
Crispim JC; Mendes-Junior CT; Wastowski IJ; Costa R; Castelli EC; Saber LT; Donadi EA
Tissue Antigens; 2008 Jan; 71(1):35-41. PubMed ID: 17971051
[TBL] [Abstract][Full Text] [Related]
64. Operational tolerance in clinical liver transplantation: emerging developments.
Tisone G; Orlando G; Angelico M
Transpl Immunol; 2007 Feb; 17(2):108-13. PubMed ID: 17306741
[TBL] [Abstract][Full Text] [Related]
65. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
[TBL] [Abstract][Full Text] [Related]
66. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
Sarwal MM
Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635
[TBL] [Abstract][Full Text] [Related]
67. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
Inston N; Drayson M; Ready A; Cockwell P
Exp Clin Transplant; 2007 Dec; 5(2):638-42. PubMed ID: 18194114
[TBL] [Abstract][Full Text] [Related]
68. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
[TBL] [Abstract][Full Text] [Related]
69. Monitoring immunosuppression with measures of NFAT decreases cancer incidence.
Giese T; Sommerer C; Zeier M; Meuer S
Clin Immunol; 2009 Sep; 132(3):305-11. PubMed ID: 19398376
[TBL] [Abstract][Full Text] [Related]
70. Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis.
Säemann MD; Sunder-Plassmann G
Transpl Immunol; 2008 Nov; 20(1-2):14-20. PubMed ID: 18804533
[TBL] [Abstract][Full Text] [Related]
71. Gene expression signature of tolerance and lymphocyte subsets in stable renal transplants: results of a cross-sectional study.
Moreso F; Torres IB; Martínez-Gallo M; Benlloch S; Cantarell C; Perelló M; Jimeno J; Pujol-Borrell R; Seron D
Transpl Immunol; 2014 Jun; 31(1):11-6. PubMed ID: 24810779
[TBL] [Abstract][Full Text] [Related]
72. Immune modulation and graft protection by gene therapy in kidney transplantation.
Sandovici M; Deelman LE; de Zeeuw D; van Goor H; Henning RH
Eur J Pharmacol; 2008 May; 585(2-3):261-9. PubMed ID: 18410915
[TBL] [Abstract][Full Text] [Related]
73. Array-based methods for diagnosis and prevention of transplant rejection.
Zhang Q; Reed EF
Expert Rev Mol Diagn; 2006 Mar; 6(2):165-78. PubMed ID: 16512777
[TBL] [Abstract][Full Text] [Related]
74. Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.
Dumontet E; Danger R; Vagefi PA; Londoño MC; Pallier A; Lozano JJ; Giral M; Degauque N; Soulillou JP; Martínez-Llordella M; Lee H; Latournerie M; Boudjema K; Dulong J; Tarte K; Sanchez-Fueyo A; Feng S; Brouard S; Conchon S
Liver Int; 2016 Mar; 36(3):401-9. PubMed ID: 26193627
[TBL] [Abstract][Full Text] [Related]
75. Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes.
Chaussabel D; Allman W; Mejias A; Chung W; Bennett L; Ramilo O; Pascual V; Palucka AK; Banchereau J
Ann N Y Acad Sci; 2005 Dec; 1062():146-54. PubMed ID: 16461797
[TBL] [Abstract][Full Text] [Related]
76. Microarrays: interrogating the transplant transcriptosome.
Shah S; Sarwal MM
Clin Transpl; 2004; ():261-7. PubMed ID: 16704157
[TBL] [Abstract][Full Text] [Related]
77. Designer genes: Filling the gap in transplantation.
Sarwal MM; Li L
Transplantation; 2006 Nov; 82(10):1261-72. PubMed ID: 17130773
[TBL] [Abstract][Full Text] [Related]
78. Identification of human cell responses to hexavalent chromium.
Gavin IM; Gillis B; Arbieva Z; Prabhakar BS
Environ Mol Mutagen; 2007 Oct; 48(8):650-7. PubMed ID: 17685462
[TBL] [Abstract][Full Text] [Related]
79. Microarrays: a monitoring tool for transplant patients?
Weintraub LA; Sarwal MM
Transpl Int; 2006 Oct; 19(10):775-88. PubMed ID: 16961768
[TBL] [Abstract][Full Text] [Related]
80. Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients.
Rodriguez RM; Hernández-Fuentes MP; Corte-Iglesias V; Saiz ML; Lozano JJ; Cortazar AR; Mendizabal I; Suarez-Fernandez ML; Coto E; López-Vázquez A; Díaz-Corte C; Aransay AM; López-Larrea C; Suarez-Álvarez B
Front Immunol; 2021; 12():709164. PubMed ID: 34489960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
